SEC 13F Intelligence

ACADIA PHARMACEUTICALS INC

CUSIP 004225109

Acadia Pharmaceuticals Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 17.0K shares worth $824,000 as of Q2 2020.

Institutional Holders
1
Q2 2020
Reported Value
$824,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
1

Ownership Trend

Institutional holders
Q2 ’20: 1Q2 ’20filingsflow.com
Total reported value
Q2 ’20: $824,000Q2 ’20filingsflow.com

Holders

··
Manager% of PortfolioValueSharesQuarter
AM INVESTMENT STRATEGIES LLC$455M AUM0.32%$824,00017.0KQ2 2020

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.